News

June 26, 2017June 26, 2017

Mesothelioma Risk Continues to Increase — 40 Years After Exposure

News

Even though 40 years have passed since their exposure to asbestos, workers’ risk of developing mesothelioma continues to rise, new research shows. Individuals exposed to asbestos four decades ago are nearly three times more ... Read more

June 23, 2017

Researchers Identify CXCR4 as Weak Therapeutic Target for Pleural Mesothelioma

News

A new study reports that a protein formerly identified as a potential therapeutic target in pleural mesothelioma, CXCR4, might not be a relevant approach for the treatment of such patients. Based ... Read more

June 22, 2017

PD-L1-positive Immune Cells May Help to Predict Survival Rates in EPMM, Study Says

News

A study that looked into France’s RENAPE Observational Registry, a database of rare peritoneal tumors, found that the presence of programmed death-ligand 1 (PD-L1) on immune cells in epithelioid peritoneal ... Read more

June 21, 2017

Combining Immunotherapy, Accelerated Radiation and Surgery Bolsters Immune Response Against Mesothelioma, Study Shows

News

Combining immunotherapy, accelerated radiation and surgery can improve immune system response against malignant pleural mesothelioma, according to a study. Immunotherapies for solid tumors have become a major focus of cancer research, ... Read more

June 20, 2017

New Way to Promote Cell Death Could Lead to Better Mesothelioma Therapies, Study Reports

News

Activating a new mechanism to promote cell death could provide hope for better mesothelioma treatments, a Japanese study indicates. The research, ”Connexin 43 enhances Bax activation via JNK activation in ... Read more

June 19, 2017June 19, 2017

Zoledronic Acid Could Be a Mesothelioma Add-On Treatment, Researchers Contend After Pilot Study

News

Zoledronic acid was only modestly active as a stand-alone therapy for advanced malignant pleural mesothelioma in a small Phase 2 pilot clinical trial. But researchers argue that its properties make ... Read more

June 16, 2017

TCR²’s Engineered Immune T-Cells Outperform More Common Class of Cells Against Mesothelioma, Studies Show

News

A key approach to treating cancer these days is engineering immune T-cells to produce receptors on their surfaces that recognize cancer, so that the T-cells can attack it. One engineering ... Read more

June 15, 2017June 15, 2017

Chemotherapy Effective in Peritoneal Mesothelioma, But Surgery Also Needs Evaluation, Researchers Say

News

Aggressive malignant peritoneal mesothelioma responds to treatment with Alimta (pemetrexed) and Platinol (cisplatin) chemotherapy, reports a study examining patient outcomes. But more studies are needed to compare chemo’s effectiveness to surgery ... Read more

June 14, 2017June 14, 2017

MicroRNAs Help Predict Pleural Mesothelioma Outcomes, European Study Finds

News

European researchers have identified two microRNAs, or small non-coding RNA molecules, that can be used to predict outcomes of malignant pleural mesothelioma, in an international study that aimed to clear up the ... Read more

June 13, 2017June 13, 2017

Prestigious Publication Highlights 2016 Scientific Advances in Thoracic Oncology

News

Last year’s progress in preventing, diagnosing and treating all forms of lung cancer, including mesothelioma, is summarized in the second annual edition of the report, “Scientific Advances in Thoracic Oncology.” published by ... Read more